| Technical Sheets |
| The Role of Biomarkers in Drug Discovery and Development |
| Poster Presentations |
Imaging an inflammatory response using 19F-MRI Poster originally presented at the 15th International Inflammation Research Association Conference (Sept 2008) |
Diffusion MRI Early Prediction of Survival Using Solvent Facilitated Perfusion of BCNU in a Rat Model of Glioma Poster originally presented at the American Association for Cancer Research 2006 Annual Meeting |
Efficacy of Temozolomide in a Transgenic Model of Glioma: MRI Determined Tumor Growth Inhibition and Diffusion Response are Predictive of Survival Poster originally presented at the American Association for Cancer Research 2006 Annual Meeting |
Intratumoral Injection of BCNU in Ethanol (DTI-015) and BCNU in Ethanol/PEG400 Cure Subcutaneous C26 Tumors Poster originally presented at the American Association for Cancer Research 2006 Annual Meeting |
MRI Predicts Tumor Grade and Survival in a tv-a Transgenic Model of Glioma Poster originally presented at the American Association for Cancer Research 2005 Annual Meeting |
MRI Determination of Temozolamide Treatment Response in a tv-a Transgenic Model of Glioma Poster originally presented at the American Association for Cancer Research 2005 Annual Meeting |
Evaluation of MRI in a Mouse Model of Liver Metastasis Poster originally presented at the American Association for Cancer Research 2005 Annual Meeting |
In vivo Micro-CT of Mouse Lungs Without Respiratory Gating Poster originally presented at the American Association for Cancer Research 2005 Annual Meeting |
In vivo Imaging of a Mouse Model of PC-3 Bone Metastasis Poster originally presented at the American Association for Cancer Research 2005 Annual Meeting |
High-throughput MRI in the use and development of preclinical mouse tumor models Poster originally presented at the American Association for Cancer Research 2005 Annual Meeting |
High field MRI characterization of tumor growth kinetics, vascularity and cellularity in a PDGF-driven tv-a mouse model of glioma Poster originally presented at the American Association for Cancer Research 2004 Annual Meeting |
Diffusion MRI in preclinical drug testing: An early surrogate marker for efficacy in subcutaneous human tumor xenografts Poster originally presented at the American Association for Cancer Research 2004 Annual Meeting |
Assessment of treatment efficacy in preclinical drug testing using magnetic resonance imaging Poster originally presented at the American Association for Cancer Research 2004 Annual Meeting |
| Articles |
Future Image Future Pharmaceuticals, Nov 2008 |
| Article Abstracts |
Structure-guided inhibitor design for human FAAH by interspecies active site conversion Proceedings of the National Academy of Sciences of the United States of America, 2008 Sep 2;105(32):12820-4. |
Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma Clinical Cancer Research, 13(10):2897-2904, May 15,2007. |
Vascular targeted nanoparticles for imaging and treatment of brain tumors Clinical Cancer Research, 12(22):6677-86, November 15, 2006. |
High-throughput magnetic resonance imaging in mice for phenotyping and therapeutic evaluation Current Opinion in Chemical Biology, 2005 Aug;9(4):413-420. |
Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4 Journal of Medicinal Chemistry, 48(7):2371-2387, April 7, 2005 |
Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts Molecular Cancer Therapeutics, 3(11):1427-37, November 2004. |
Use of Magnetic Resonance Imaging for Evaluation of Treatment Response Appears in "Mouse Models of Human Cancer” |
A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI Molecular Imaging, 2(4):324-32, 2003 |
Evaluation of cancer therapy using diffusion magnetic resonance imaging Molecular Cancer Therapeutics, 2(6):581-7, 2003. |